Besides, brain or spinal cord tumors remain difficult types of cancers to treat, such as glioblastoma (GBM), even after four PARP inhibitors were approved by FDA as PARP1 overexpression is present in various cancers (55). Here, PARP1 is linked to spinal cord neoplasm.